Carbon dioxide retention occurs during water immersion. Therefore, we tested the hypothesis that central chemosensitivity to hypercapnia is blunted during 2 h of thermoneutral head-out water immersion (HOWI) in healthy young adults. Twenty-six participants (age 22 ± 2 years; body mass index 24 ± 3 kg m −2 ; 14 women) participated in two experimental visits: a HOWI visit (HOWI) and a dry time-control visit (Control). Central chemosensitivity was assessed via a rebreathing test at baseline, 10, 60, 90 and 120 min and after HOWI and Control. End-tidal CO 2 tension (P ET,CO 2 ), minute ventilation, blood pressure and heart rate were recorded continuously.
INTRODUCTION
Carbon dioxide (CO 2 ) retention is defined as an increase in arterial CO 2 content above resting values (Lanphier & Bookspan, 1999) . CO 2 retention occurs during water immersion (Bennett & Elliott, 1975; Cherry et al., 2009; Lanphier & Bookspan, 1999; Löllgen, von Nieding, & Horres, 1980; Mummery et al., 2003; Pendergast & Lundgren, 2009; Pendergast, Moon, Krasney, Held, & Zamparo, 2015; Sackett, Schlader, Sarker, Chapman, & Johnson, 2017; Salzano, Camporesi, Stolp, & Moon, 1984; Warkander, Norfleet, Nagasawa, & Lundgren, 1990) , which increases the risk of CO 2 toxicity (Bennett & Elliott, c Lanphier & Bookspan, 1999; Warkander et al., 1990) . Thus, determining the physiological mechanisms that contribute to CO 2 retention is important for diver safety. Water immersion increases transthoracic pressure (i.e. static lung load), which increases the work of breathing and alters ventilation (Pendergast & Lundgren, 2009; Pendergast et al., 2015) . Moreover, central hypervolaemia during water immersion increases ventilatory dead space and causes hypoventilation (Hickey, Norfleet, Pasche, & Lundgren, 1987; Lanphier & Bookspan, 1999; Salzano, Rausch, & Saltzman, 1970; Thalmann, Sponholtz, & Lundgren, 1979; Warkander et al., 1990) . Therefore, hypoventilation may contribute
New Findings
• What is the central question of the study?
Is central chemosensitivity blunted during thermoneutral head-out water immersion in healthy humans?
• What is the main finding and its importance?
Central chemosensitivity is augmented during thermoneutral head-out water immersion in healthy men and women. Thus, we suggest that the central chemoreceptors do not contribute to CO 2 retention during head-out water immersion.
to CO 2 retention during water immersion Pendergast et al., 2015) . Additional factors contributing to hypoventilation and CO 2 retention during water immersion include immersion depth, inspired partial pressure of oxygen, breathing resistance, aerobic fitness and baseline central chemosensitivity Jarrett, 1966; Kerem, Daskalovic, Arieli, & Shupak, 1995; Kerem, Melamed, & Moran, 1980; Lambertsen et al., 1959; Lanphier & Bookspan, 1999; Löllgen et al., 1976; Pendergast & Lundgren, 2009; Pendergast et al., 2015; Salzano et al., 1984; Warkander et al., 1990) .
Ventilatory control in humans is modified by input from the peripheral and central chemoreceptors (Kara, Narkiewicz, & Somers, 2003) . When these receptors are stimulated by an increase in arterial CO 2 content, a compensatory increase in ventilation occurs (Nattie & Li, 2012) . We recently found that peripheral chemosensitivity to hypercapnia and hypoxia is not altered during 2 h of thermoneutral head-out water immersion (HOWI; Sackett et al., 2017) . This was despite an increase in the partial pressure of end-tidal CO 2 (P ET,CO 2 ), which indicates an increase in arterial CO 2 content McSwain et al., 2010; Mummery et al., 2003; Salzano et al., 1984) .
Thus, the peripheral chemoreceptors do not appear to contribute to CO 2 retention during thermoneutral HOWI while breathing room air. However, the central chemoreceptors, located in the brainstem, medulla and spinal cord, are the primary CO 2 sensors (Nattie & Li, 2012) . Therefore, the ability of the central chemoreceptors to become activated during water immersion could contribute to CO 2 retention. Chang and Lundgren (1995) have shown that central chemosensitivity is not altered during 10 min of thermoneutral HOWI. However, it is not known whether central chemosensitivity is altered beyond 10 min of HOWI. Moreover, Cherry et al. (2009) suggest that baseline central chemosensitivity predicts the degree of CO 2 retention during water immersion, such that a low baseline central chemosensitivity is associated with greater hypercapnia while diving at 4.7 atmospheres absolute. Importantly, divers possess a lower central chemosensitivity than control subjects during rest and exercise (Earing, McKeon, & Kubis, 2014) , which might predispose them to an increased risk of CO 2 toxicity. To this end, it is not known whether participants with a low baseline central chemosensitivity will have different ventilatory responses to water immersion from participants with a high baseline central chemosensitivity.
The objectives of our study were as follows: (i) to assess central chemosensitivity via a rebreathing test before, during and after 2 h of thermoneutral HOWI in healthy humans; and (ii) to determine whether participants with low and high baseline central chemosensitivity have different ventilatory responses during HOWI. We hypothesized that: (i) central chemosensitivity would be blunted throughout 2 h of thermoneutral HOWI; and (ii) participants with a low baseline central chemosensitivity would experience greater CO 2 retention during water immersion.
METHODS

Ethical approval
Participants were recruited at random from the student body at the University at Buffalo. Participants gave written informed consent before any experimental visits. The study was performed in accordance with the latest standards set forth by the Declaration of Helsinki, except for registration in a database. Furthermore, all experimental procedures were approved by the Institutional Review Board at the University at Buffalo (ID: STUDY00001177).
Participants
Twenty-six participants (age 22 ± 2 years; body mass index 24 ± 3 kg m −2 ; 14 women) completed four visits to the laboratory: a screening visit, a familiarization visit and two randomized experimental visits. Participants self-reported to be active non-smokers and were not taking medications. Participants also self-reported to be free from any known cardiovascular, metabolic, neurological or psychological disease. Women were not pregnant, confirmed via a urine pregnancy test, and were tested during the first 10 days after self-identified menstruation to control for menstrual cycle hormones (Minson, Halliwill, Young, & Joyner, 2000) . During the screening visit, each participant was informed of the experimental procedures and possible risks before giving written consent. During the familiarization visit, each participant was acquainted with the breathing apparatus (i.e. the mouthpiece and rebreathing bag) and gases that would be used during the experimental trials.
Instrumentation and measurements
Height and weight were measured with a stadiometer and scale (Sartorius Corp., Bohemia, NY, USA). Urine specific gravity was measured using a refractometer (Atago USA, Inc., Bellevue, WA, USA). During water immersion, core temperature was measured via a telemetry pill (HQ, Inc., Palmetto, FL, USA) that was swallowed the night before the experiment. During the Control visit, we measured oral temperature using a thermometer (Welch Allyn Inc., Skaneateles Falls, NY, USA). The P ET,CO 2 was measured using a capnograph (Nonin Medical, Inc., Plymouth, MN, USA). Given that P ET,CO 2 reflects arterial CO 2 content throughout a wide range of physiological dead space (McSwain et al., 2010) , including water immersion Mummery et al., 2003; Salzano et al., 1984) , P ET,CO 2 was used as a marker of arterial CO 2 content. Inspired and expired ventilation was measured using a heated pneumotachometer (Hans Rudolph, Inc., Shawnee, KS, USA) that was attached to a mouthpiece (Hans Rudolph, Inc.). Beat-to-beat blood pressure was measured via the Penaz method (ccNexfin Bmeye NA, St Louis, MO, USA) on the left hand, which was suspended above the water during HOWI. Blood pressure was corrected to heart level using a height correction sensor. Heart rate was measured from a three-lead ECG (DA100C; Biopac Systems, Inc., Goleta, CA, USA). Stroke volume was determined via the arterial pressure waveform using Modelflow (ccNexfin Bmeye NA), and cardiac output was calculated as the product of heart rate and stroke volume.
Total peripheral resistance was calculated as mean arterial pressure divided by cardiac output.
Ventilatory data were captured at 62 Hz and haemodynamic data at 1 kHz by a data acquisition system (Biopac MP 150) and stored on a personal computer for offline analyses. Data were measured continually at each time point during baseline, the rebreathing test, and recovery (i.e., ∼12 minutes), but not throughout the entire experimental visit, such that the mouthpiece and finger blood pressure cuff were removed between time points. Minute ventilation, tidal volume and respiratory rate were determined using the breath-bybreath respiratory analysis feature of the data analysis software (BIOPAC Systems, Inc., AcqKnowledge 4.2; Goleta, CA, USA). Aberrant breaths (e.g. sigh, breath hold) were manually excluded, and ventilation data are presented at body temperature and pressure when saturated with water vapour (BTPS). The fraction of expired CO 2 was calculated as the partial pressure of mean expired CO 2 (i.e. derived from the CO 2 waveform) divided by barometric pressure minus water vapour pressure of the body (Siobal, Ong, Valdes, & Tang, 2013) . The rate of CO 2 production was calculated as the product of the fraction of expired CO 2 and minute ventilation. Alveolar ventilation was calculated as the product of the rate of CO 2 production and 863 divided by P ET,CO 2 (West, 2012) . Dead space ventilation was calculated as minute ventilation minus alveolar ventilation. The ratio of alveolar ventilation to cardiac output was calculated as an index of the ratio of alveolar ventilation to pulmonary perfusion (Derion et al., 1992; Levitzky, 2013) .
Rebreathing test
A rebreathing test was used to calculate central chemosensitivity and central chemoreflex threshold (Read, 1967; Rebuck, 1976) .
Participants rebreathed through a 10 litre bag that contained 7% CO 2 and 93% O 2 for 3.5 min. The volume of the gas in the bag was equal to predicted vital capacity (Casio, 2017 ) plus 1 litre. The test began with the participant taking three deep breaths in order to achieve equilibrium in the CO 2 waveform quickly. Central chemosensitivity was calculated by plotting the mean minute ventilation versus mean P ET,CO 2 every 30 s throughout the rebreathing test beginning after the first 30 s of the test. Central chemosensitivity data are reported as the slope of the linear regression line for the ventilatory responses to hypercapnia. Furthermore, the x-intercept of the linear regression line of mean minute ventilation versus mean P ET,CO 2 represents the theoretical value of P ET,CO 2 at which ventilation is 0 l min −1 (i.e. central chemoreflex threshold; Read, 1967) . We also calculated the rate at which minute ventilation and P ET,CO 2 increased over time throughout each rebreathing test. These data provide insight into which variable (i.e. minute ventilation or P ET,CO 2 ) is contributing to changes in central chemosensitivity. Minute ventilation and P ET,CO 2 increase linearly during a breathing test, such that the increases in minute ventilation and P ET,CO 2 over time are typically similar at any given point during the rebreathing test. Furthermore, these values are consistent during repeated rebreathing tests (Fowle & Campbell, 1964) . The increases in minute ventilation and P ET,CO 2 over time were calculated as the change in minute ventilation and P ET,CO 2 , respectively, from the beginning to the end of the test divided by the change in time (i.e. 3.5 min; Fowle & Campbell, 1964) .
Experimental approach
The two randomized experimental visits comprised: (i) a HOWI visit (HOWI); and (ii) a time-control visit (Control). Participants arrived at the laboratory having refrained from strenuous exercise, alcohol and caffeine for 12 h and food for 2 h for both visits. Participants also arrived to the laboratory euhydrated for both HOWI (urine specific gravity 1.009 ± 0.007) and Control visits (urine specific gravity 1.008 ± 0.006). Participants wore shorts and a t-shirt/sports bra during all experimental visits. Participants assumed a seated position for instrumentation in a temperature-controlled laboratory (24 ± 2 • C, 46 ± 14% relative humidity). After ≥10 min of seated rest, a baseline rebreathing test commenced. Upon the completion of baseline measurements, the participants either entered a pool (HOWI) or continued seated rest (Control) for 2 h. The HOWI consisted of seated rest in thermoneutral water (35.0 ± 0.1 • C) up to the suprasternal notch. We used thermoneutral water (∼35 • C) during HOWI in an attempt to eliminate the thermal effect of water. To this end, thermoneutral water immersion increases skin temperature but does not alter core temperature (Craig & Dvorak, 1966; Pendergast et al., 2015) . Over the next 2 h, a rebreathing test began at 10, 60, 90 and 120 min. Then, participants exited the pool (HOWI) or remained seated (Control), and a rebreathing test began after 10 min of seated rest (i.e. post). During the experimental visits, participants were encouraged to breathe spontaneously as they viewed a non-stimulating documentary.
Data and statistical analyses 2.6.1 HOWI versus Control
These data were assessed for approximation to a normal distribution, and an outlier analysis was necessary. Outliers were identified and removed using the ROUT method (Motulsky & Brown, 2006) . The Q value, or the false-discovery rate, was set conservatively (i.e. 0.1%) so that only definitive outliers were removed. Outliers were removed from statistical analyses for P ET,CO 2 (n = 1), dead space ventilation (n = 2), tidal volume (n = 2), central chemosensitivity (n = 1), central chemoreflex threshold (n = 5) and increase in minute ventilation over time (n = 2). After outliers were removed, data were analysed using a two-way repeated-measures ANOVA. If a significant interaction or main effect was found, the Holm-Sidak multiple comparisons post hoc test was used to determine where differences existed. The effect size (i.e. Cohen's d) was calculated for all significant pairwise comparisons.
Low versus High
After the completion of all experimental trials, participants were All data were analysed using Prism software (version 6; GraphPad Software Inc., La Jolla, CA, USA). Data are reported as means ± SD, and
exact P values are reported where possible. All data were analysed and reported as a change from baseline. 
RESULTS
HOWI versus
Intestinal temperature
Intestinal temperature decreased from baseline during HOWI at 
Ventilation
Baseline values are presented in Table 1 . The P ET,CO 2 ( Figure 1a) increased from baseline during HOWI at 10 min (P < 0.001, d = 1.04), 60 min (P < 0.001, d = 1.74), 90 min (P < 0.001, d = 1.86) and 120 min (P < 0.001, d = 2.04). Moreover, the change in P ET,CO 2 during HOWI was greater than that in Control at 10 min (P < 0.001, d = 1.05), 
Haemodynamics
Baseline values are presented in Table 1 
Rebreathing test
Baseline values are presented in Table 1 and increased from baseline during HOWI at post (P < 0.001, d = 1.12).
Furthermore, the change in increase in P ET,CO 2 over time during the rebreathing test during HOWI was lower than that during Control at every time point (P < 0.001 for all, d ≥ 0.66).
Low versus High
Ventilation
Baseline values are presented in Table 2 . 
Haemodynamics
Baseline values are presented in Table 2 . There were no statistical differences during HOWI in Low and High for the change in mean arterial pressure across time (time main effect: P = 0.068) or between groups (group main effect: P = 0.843). Likewise, there were no statistical differences during HOWI in Low and High for the change in cardiac output and the change in total peripheral resistance across time (P ≥ 0.062) or between groups (group main effect: P ≥ 0.146).
Furthermore, there were no statistical differences during HOWI in Low and High for the change in heart rate across time (P ≥ 0.059) or between groups (group main effect: P = 0.192). There were no statistical differences during HOWI in Low and High for the change in stroke volume across time (P ≥ 0.084) or between groups (group main effect: P = 0.974). Finally, there were no statistical differences during HOWI in Low and High for the change in the ratio of alveolar ventilation to cardiac output across time (P ≥ 0.053) or between groups (group main effect: P = 0.339). 
Control HOWI F I G U R E 2 Mean arterial pressure (a), cardiac output (b), total peripheral resistance (c), heart rate (d), stroke volume (e) and ratio of alveolar ventilation to cardiac output (f) at baseline, 10, 60, 90 and 120 min and post HOWI and Control. Values are means ± SD. * Different from Control, P < 0.050. B Different from baseline, P < 0.050
Rebreathing test
Baseline values are presented in Table 2 . Central chemosensitivity There were no statistical differences for the change in increase in minute ventilation over time during the rebreathing test (Figure 5c ) throughout HOWI (P ≥ 0.168) or between groups (group main effect: P = 0.707). The increase in P ET,CO 2 over time during the rebreathing test (Figure 5d ) decreased from baseline during HOWI in both groups at 10 min (P < 0.001 for both, d = 3.14 for both), 60 min (P < 0.001 for both, d ≥ 3.30 for both), 90 min (P < 0.001 for both, d ≥ 3.68 for both) and 120 min (P < 0.001 for both, d = 2.95 for both). Furthermore, the increase in P ET,CO 2 over time during the rebreathing test also increased from baseline during HOWI in Low at post (P = 0.004, d = 1.13).
DISCUSSION
Contrary to our hypothesis, our new finding is that central chemo- 
HOWI versus Control
Ventilation
Similar to previous findings Jarrett, 1966; Kerem et al., 1995; Miyamoto et al., 2014; Salzano et al., 1970 Salzano et al., , 1984 ,
we observed an increase in P ET,CO 2 throughout water immersion ( Figure 1a) . The primary cause of CO 2 retention during underwater diving is traditionally considered to be hypoventilation, specifically through a reduced alveolar ventilation caused by an increased work of breathing and increased dead space (Mummery et al., 2003; Salzano et al., 1984) . However, the increase in work of breathing and dead space ventilation during HOWI are likely to be less than what is seen during immersion at depth Hickey et al., 1987; Mummery et al., 2003; Salzano et al., 1984) . To this end, the ventilatory data from the present study and our previous work (Sackett et al., 2017) indicate that minute ventilation and alveolar ventilation are not attenuated throughout HOWI compared with Control (Figure 1b, c) .
Thus, CO 2 retention during HOWI does not appear to be related to an attenuated minute or alveolar ventilation. Moreover, Miyamoto et al.
(2014) observed a rightward shift in the respiratory operating point (i.e. minute ventilation versus P ET,CO 2 ) during thermoneutral HOWI that might increase the likelihood of CO 2 retention. Our data at rest agree with their findings, in that we also observed a rightward shift of the respiratory operating point and CO 2 retention.
We observed decreases in tidal volume and increases in respiratory rate during HOWI (Figure 1e, f) . These changes in respiratory pattern, which are probably attributable to enhanced negative pressure breathing (i.e. negative static lung load; Pendergast & Lundgren, 2009 ), might contribute to CO 2 retention during water immersion (Ray, Pendergast, & Lundgren, 2010; Sackett et al., 2017) . Furthermore, water immersion increases the work of breathing (Collett & Engel, 1986; Otis, Fenn, & Rahn, 1950) . However, previous investigators suggest that an increased work of breathing is not directly related to CO 2 retention Norfleet et al., 1987; Thalmann et al., 1979) . Furthermore, it is unknown whether an increased work of breathing during HOWI is mitigated via alterations in respiratory pattern . It has been suggested that a reduced alveolar ventilation, and subsequent CO 2 retention, occurs in place of the increased work of breathing that would be required to prevent CO 2 retention during water immersion (Lundgren & MIller, 1999; Mummery et al., 2003; Ray, Pendergast, & Lundgren, 2008 Salzano et al., 1984) . Thus, we speculate that HOWI might induce alterations in breathing pattern to minimize the work of breathing, Central chemosensitivity (l min
TA B L E 2 Baseline values during HOWI for Low and High
Central chemoreflex threshold (mmHg) 35 ± 6* 42 ± 4 0.015
Increase in minute ventilation over time (l min −2 ) 7 . 6 ± 2.1 16.0 ± 4.4 0.000
Increase in P ET,CO 2 over time (mmHg min −1 ) 6 ± 1 6 ± 1 0.924
Values are means ± SD. Abbreviations: HOWI, head-out water immersion; and P ET,CO 2 , partial pressure of end-tidal carbon dioxide. * Different from High, P < 0.050. which subsequently leads to CO 2 retention. In this context, although the changes we observed in breathing pattern did not significantly affect minute ventilation, we speculate that the cumulative change in breathing pattern over time might have contributed to CO 2 retention. However, this idea requires further investigation. To this end, measuring the work of breathing, respiratory muscle mechanics and/or neural respiratory drive during water immersion might lend additional insight into the underlying mechanisms of CO 2 retention.
Increases in rectal temperature may contribute to altered breathing patterns and minute ventilation (Tipton, Harper, Paton, & Costello, 2017; White, 2006) . A previous investigation indicates that thermoneutral water heats the integument during HOWI, while not altering core temperature (Craig & Dvorak, 1966) . Albeit a small effect, intestinal temperature decreased during HOWI in our investigation. To this end, it does not appear that small reductions (∼0.2 • C) in intestinal temperature contribute to an altered breathing pattern (Frank et al., 1997; Tipton et al., 2017) . In this context, we suggest that an altered breathing pattern during water immersion is most likely to be a result of the hydrostatic pressure of the water (i.e. static lung load; Moon, Cherry, Stolp, & Camporesi, 2009 ).
Haemodynamics
The prevailing theory is that mean arterial pressure initially increases during water immersion because of a redistribution of blood volume from the periphery to the thorax (Arborelius, Ballidin, Lilja, & Lundgren, 1972; Pendergast & Lundgren, 2009; Pendergast et al., 2015) . The redistribution of blood subsequently causes diuresis and a return of mean arterial pressure to baseline values after continued immersion (Arborelius et al., 1972; Pendergast et al., 2015 et al., 2015; Srámek, Simecková, Janský, Savlíková, & Vybíral, 2000; Watenpaugh, Pump, Bie, & Norsk, 2000) or slightly decreases (Craig & Dvorak, 1966; Sackett et al., 2017) during water immersion. During our study, mean arterial pressure was not different during HOWI compared with Control at any time point (Figure 2a ). After 10 min of HOWI, we observed a 9 ± 14% increase in cardiac output and a −6 ± 13% decrease in total peripheral resistance, which contributed to the unchanged mean arterial pressure. The return to baseline cardiac output and total peripheral resistance values after 10 min of HOWI were most probably attributable to diuresis, which is evidenced by the increase in urine output during HOWI.
Rebreathing test
Our data indicate that central chemosensitivity is augmented throughout thermoneutral HOWI (Figure 3a) . Therefore, although the sensitivity of the central chemoreceptors was augmented during HOWI, the increase in chemosensitivity did not mitigate CO 2 retention. Furthermore, we observed a rightward shift of the central chemoreflex threshold (Figure 3b ) throughout HOWI. However, it is unclear whether these changes are related to the increase in P ET,CO 2 and/or the increase in central chemosensitivity during water immersion, because we also observed a rightward shift of the central chemoreflex threshold during Control at 60 and 90 min and post.
The increased central chemosensitivity that we observed might be associated with a slower increase in P ET,CO 2 over time during the rebreathing test during HOWI compared with Control ( Figure 3d ).
The increase in P ET,CO 2 over time during a rebreathing test in Control conditions is ∼6 mmHg min −1 , independent of the participant, bag size and gas concentration (Fowle & Campbell, 1964) . A slower increase in P ET,CO 2 over time during rebreathing has been found previously during 10 min of HOWI (Chang & Lundgren, 1995) , and it is thought that this
Baseline 10 We speculate that the slower increase in P ET,CO 2 over time might be explained, in part, by enhanced bicarbonate buffering during water immersion (Epstein, 1992) . Epstein (1992) found an increased pH and P CO 2 of the urine and an increased rate of bicarbonate excretion during thermoneutral water immersion, which indicates that CO 2 might be redistributed in the form of bicarbonate to the renal system and concentrated in the urine during water immersion. However, we did not analyse urine excretion for pH, P CO 2 or bicarbonate and we are therefore unable to confirm these findings. Furthermore, it has been speculated that the stomach might act in a similar manner to a lung during water immersion and take up CO 2 in an attempt to prevent respiratory acidosis (Dean, 2011) . This novel idea of gastric CO 2 ventilation might help to explain the slower increase in P ET,CO 2 over time during rebreathing that we and others (Chang & Lundgren, 1995) have observed during water immersion, but experimental evidence of this occurring in humans is not currently available.
Low versus High
Ventilation
Although we did not observe differences in P ET,CO 2 (Figure 4a had an earlier decrease in tidal volume (i.e. Low) experienced hypercapnia earlier during water immersion. These data agree with previous investigations that suggest hypercapnia might be associated with shallow breathing (Gorini et al., 1996; Ray et al., 2008 Ray et al., , 2010 Sackett et al., 2017) . Although it appears that CO 2 retention might be related to the breathing pattern during water immersion, this idea requires further investigation. Nevertheless, a high baseline central chemosensitivity might contribute to the delayed onset of CO 2 retention during water immersion. In this context, participants with a low baseline central chemosensitivity might be susceptible to an earlier onset of CO 2 retention during water immersion than participants with a high baseline central chemosensitivity. However, it does not appear that the peak increase in P ET,CO 2 during HOWI is dictated by baseline central chemosensitivity. The temporal P ET,CO 2 response between 10 and 60 min of HOWI in both groups is also currently unclear. To this end, it is possible that P ET,CO 2 increased shortly after the 10 min measurement time point in the Low group.
Rebreathing test
Central chemosensitivity (Figure 5a ) increases from baseline throughout water immersion during HOWI in High, whereas the increase is delayed and not present until 60 min in Low. This delay contributes to the idea that participants with a low baseline central chemosensitivity might be at a greater risk for CO 2 retention during water immersion . A delayed increase in central chemosensitivity might allow an earlier onset of hypercapnia during water immersion. However, these findings do not appear to be related to the magnitude of the increase in P ET,CO 2 , because there were no differences between groups. Conversely, changes in the central chemoreflex threshold might provide insight into these findings.
We speculate that an increase (i.e. rightward shift) in the central chemoreflex threshold from baseline throughout HOWI in Low might put this group at greater risk for hypercapnia during water immersion.
However, the underlying mechanisms for these differences have yet to be studied and require further investigation.
Perspectives
Although the degree of CO 2 retention induced during thermoneutral HOWI is not considered clinically significant (Moloney, Kiely, & McNicholas, 2001) , the mechanisms that contribute to CO 2 retention during HOWI merit investigation because of the potential perilous consequences of CO 2 toxicity during diving (Lanphier & Bookspan, 1999; Warkander et al., 1990) . High arterial CO 2 content during water immersion induces the onset of several symptoms, including breathlessness, headaches, dizziness, poor concentration and visual distortions (Fothergill, Taylor, & Hyde, 1998) . Furthermore, CO 2 toxicity may cause an unexpected loss of consciousness in divers (Lanphier & Bookspan, 1999) . Our data indicate that central chemosensitivity is augmented during HOWI, probably in an attempt to mitigate CO 2 retention. However, central hypervolaemia during water immersion might enhance CO 2 redistribution and alter the central chemoreflex threshold, favouring CO 2 retention. In combination with our previous work (Sackett et al., 2017) , these data indicate that alterations in the chemical control of breathing do not appear to contribute to CO 2 retention during water immersion.
Considerations
Our study has several limitations. Firstly, CO 2 retention occurred throughout HOWI. Therefore, the rebreathing test began at a higher P ET,CO 2 during HOWI than during Control. The mild hypercapnic background might have activated the central chemoreceptors and potentially altered central chemosensitivity. However, because ventilation was unchanged throughout HOWI, we speculate that this did not contribute to our findings. Secondly, none of the participants in our study was an active underwater diver. Thus, it is unknown whether these findings would be similar in a population of divers, who appear to have an attenuated central chemosensitivity compared with control subjects during rest and exercise (Earing et al., 2014) .
Thirdly, investigating the differences between participants with a low baseline central chemosensitivity versus participants with a high baseline central chemosensitivity (i.e. Low versus High) was not an a priori comparison. Therefore, the study was not powered to detect differences between these groups. Finally, the participants were aware of when the rebreathing test began because they were able to observe when the three-way valve was switched from room air to the rebreathing bag. Consequently, it is possible that participants altered their ventilation upon initiation of the rebreathing test. However, we believe that this effect was minimized by the familiarization visit, encouraging participants to remain relaxed and breathe spontaneously throughout the study, and having identical methods during HOWI and Control.
Conclusions
In summary, 2 h of thermoneutral HOWI caused an increase in central chemosensitivity that was accompanied by an increase in P ET,CO 2 despite no changes in ventilation. Therefore, we suggest that changes to central chemosensitivity do not appear to contribute to CO 2 retention during HOWI. However, the slower increase in P ET,CO 2 over time during the rebreathing test might contribute to CO 2 retention during thermoneutral HOWI in healthy young adults.
Furthermore, participants with a low baseline central chemosensitivity might experience an earlier onset of hypercapnia than participants with a high baseline central chemosensitivity.
